BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9452367)

  • 1. 9p21 deletions in primary melanoma.
    Naylor MF; Brown S; Quinlan C; Pitha JV; Evertt MA
    Dermatol Online J; 1997 Dec; 3(2):1. PubMed ID: 9452367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.
    An HX; Niederacher D; Picard F; van Roeyen C; Bender HG; Beckmann MW
    Genes Chromosomes Cancer; 1996 Sep; 17(1):14-20. PubMed ID: 8889502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A mutation and deletion status in thin and thick primary melanoma.
    Cachia AR; Indsto JO; McLaren KM; Mann GJ; Arends MJ
    Clin Cancer Res; 2000 Sep; 6(9):3511-5. PubMed ID: 10999737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma.
    Holland EA; Beaton SC; Edwards BG; Kefford RF; Mann GJ
    Oncogene; 1994 May; 9(5):1361-5. PubMed ID: 8152796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi.
    Indsto JO; Cachia AR; Kefford RF; Mann GJ
    Clin Cancer Res; 2001 Dec; 7(12):4054-9. PubMed ID: 11751501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
    Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
    Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma ex naevo: a study of the associated naevus.
    Bogdan I; Smolle J; Kerl H; Burg G; Böni R
    Melanoma Res; 2003 Apr; 13(2):213-7. PubMed ID: 12690309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 9 deletion in sporadic and familial melanomas in vivo.
    Isshiki K; Seng BA; Elder DE; Guerry D; Linnenbach AJ
    Oncogene; 1994 Jun; 9(6):1649-53. PubMed ID: 8183559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
    Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
    Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1994 Mar; 54(6):1422-4. PubMed ID: 8137242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions.
    Walker GJ; Palmer JM; Walters MK; Nancarrow DJ; Parsons PG; Hayward NK
    Oncogene; 1994 Mar; 9(3):819-24. PubMed ID: 8108124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma.
    Fujimoto A; Morita R; Hatta N; Takehara K; Takata M
    Oncogene; 1999 Apr; 18(15):2527-32. PubMed ID: 10229204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
    Grafström E; Egyházi S; Ringborg U; Hansson J; Platz A
    Clin Cancer Res; 2005 Apr; 11(8):2991-7. PubMed ID: 15837753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
    Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
    Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
    Merbs SL; Sidransky D
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):779-83. PubMed ID: 10067984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group.
    Palmieri G; Cossu A; Ascierto PA; Botti G; Strazzullo M; Lissia A; Colombino M; Casula M; Floris C; Tanda F; Pirastu M; Castello G;
    Br J Cancer; 2000 Dec; 83(12):1707-14. PubMed ID: 11104570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.